Two Sigma Securities »

Crinetics Pharmaceuticals In shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $367k 7.8k 46.81

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Point72 Asset Management
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Paradigm Biocapital Advisors
Jennison Associates
T. Rowe Price Investment Management
Henderson Group
First Light Asset Management
Perceptive Advisors
Geode Capital Management
Artal Group

View all funds holding Crinetics Pharmaceuticals In